Dapat Clyde, Oshitani Hitoshi
a Department of Virology , Tohoku University Graduate School of Medicine , Sendai , Miyagi Prefecture , Japan.
Expert Rev Anti Infect Ther. 2016;14(3):285-97. doi: 10.1586/14787210.2016.1141676. Epub 2016 Feb 3.
The lack of vaccine and limited antiviral options against respiratory syncytial virus (RSV) highlights the need for novel therapeutic strategies. One alternative is to develop drugs that target host factors required for viral replication. Several microarray and proteomics studies had been published to identify possible host factors that are affected during RSV replication. In order to obtain a comprehensive understanding of RSV-host interaction, we integrated available proteome and transcriptome datasets and used it to construct a virus-host interaction network. Then, we interrogated the network to identify host factors that are targeted by the virus and we searched for drugs from the DrugBank database that interact with these host factors, which may have potential applications in repositioning for future treatment options of RSV infection.
针对呼吸道合胞病毒(RSV)缺乏疫苗且抗病毒选择有限,这凸显了新型治疗策略的必要性。一种替代方法是开发针对病毒复制所需宿主因子的药物。已经发表了几项微阵列和蛋白质组学研究,以确定在RSV复制过程中可能受到影响的宿主因子。为了全面了解RSV与宿主的相互作用,我们整合了可用的蛋白质组和转录组数据集,并利用它构建了一个病毒-宿主相互作用网络。然后,我们对该网络进行查询,以识别被病毒靶向的宿主因子,并从药物银行数据库中搜索与这些宿主因子相互作用的药物,这些药物可能在重新定位RSV感染的未来治疗选择方面具有潜在应用。